Newsletter | June 9, 2021

06.09.21 -- Exosomes' Therapeutic Potential, AAV and Lentiviral Gene Therapies, and more from the Business of Biotech Podcast

Listen Now: Our Latest Podcast Episodes

Check out the latest episodes from The Business of Biotech and Life Science Connect. As a member of the Life Science Connect community, you have access to content beyond our weekly newsletters, including our podcast series. Don’t forget to subscribe so you never miss an episode!


AAV And Lentiviral Gene Therapies With Sio's Dr. Pavan Cheruvu

Fresh on the heels of a significant data readout on its AXO-AAV-GM1 candidate at the recent ASGCT meeting, Sio Gene Therapies CEO, Pavan Cheruvu, M.D., joins the Business of Biotech podcast to discuss his company's progress developing adeno-associated virus (AAV) and lentiviral gene therapies to treat GM1 gangliosidosis, Tay-Sachs/Sandhoff disease, and Parkinson's disease.

Med Device Meets Biopharma With OncoSec's Dan O'Connor, J.D.

OncoSec CEO, Dan O'Connor, joins the Business of Biotech podcast to discuss his company's development of proprietary application and injection technologies for direct delivery of its pipeline of immunotherapeutic candidates and combination therapies into the tumor environment.

Drug Development: From Bench To Bedside With Allan Shaw

CFO to the biopharma stars and frequent Business of Biotech guest Allan Shaw shares the keys to efficiency as you move your candidate from the bench to the bedside. Shaw addresses the common perils of insular thinking in biopharma and offers practical advice for avoiding those pitfalls.

Digital Transformation In Cell Therapy With Organicell Drs. Mari Mitrani And Michael Bellio

Drs. Mari Mitrani and Michael Bellio are young pioneers in the study of the therapeutic potential of exosomes. On this episode of the Business of Biotech they offer insight into the digital discovery and manufacturing automation technologies in use at Organicell.


Cell And Gene Bottlenecks And Challenges

Erin Harris, chief editor of, explains what makes cell and gene therapy manufacturing more complex and what some of the current hurdles and bottlenecks are that companies in this sector of life sciences face.

What's Happening On The Front Lines Of COVID-19: A CEO Roundtable On Technologies In Development For The Current Pandemic

Four biopharmaceutical industry CEOs and company cofounders converse on what their organizations are doing to spur the development of diagnostic tests, therapeutics, and vaccines in order to turn the tide on the COVID-19 pandemic.

Accelerating Your Biopharma Startup's Path To The Clinic

Pamela Contag, Ph.D., cofounder and CEO of BioEclipse Therapeutics, a clinical-stage oncology company, and Dara Lockert, founder and executive director of Spannerwerks, a life sciences industry consultancy, share best practices and lessons learned during the drive to get a biopharmaceutical startup to the clinic as quickly as possible.